Document is current

Any future updates will be listed below

Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway

Crossref DOI link: https://doi.org/10.1007/s13277-015-3232-6

Published Online: 2015-02-21

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark